Fabricants
Médicaments de TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
11 médicaments dont TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD. détient l’autorisation en France.
Actos 15 mg comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Actos 30 mg, comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Actos 45 mg, comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Competact 15 mg/850 mg comprimés pelliculésTAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Glubrava 15 mg/850 mg comprimés pelliculésTAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Glustin 15 mg, comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Glustin 30 mg, comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Glustin 45 mg, comprimésPioglitazone · TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Tandemact 30 mg/ 4 mg, comprimésTAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Tandemact 30 mg/2 mg, comprimésTAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Tandemact 45 mg/ 4mg, comprimésTAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD.
Publicité